Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Electromyography Signals as Biomarkers for Parkinson's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02168504
Recruitment Status : Completed
First Posted : June 20, 2014
Last Update Posted : October 8, 2015
Sponsor:
Collaborator:
Michael J. Fox Foundation for Parkinson's Research
Information provided by (Responsible Party):
Norconnect Inc

Brief Summary:
A simple, painless and reliable method to detect Parkinson's disease at an early stage is very important to patients, doctors and researchers. Doctors want to help patients early, and scientists want to select patients for their research who will help in development of better drugs. We hope that the changes in electrical activity of hand muscles during handwriting will help in early detection of this disease.

Condition or disease
Parkinson's Disease

Show Show detailed description

Layout table for study information
Study Type : Observational
Actual Enrollment : 20 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Electromyography Signals as Biomarkers for Parkinson's Disease
Study Start Date : June 2014
Actual Primary Completion Date : September 2015
Actual Study Completion Date : September 2015

Resource links provided by the National Library of Medicine


Group/Cohort
Healthy controls
Healthy male and female subjects older than 18 years of age without the symptoms of Parkinson's disease. The ages of subjects in this group will be matching to the ages of subjects in Parkinson's disease group
Parkinson's disease patients
male and female subjects older than 18 years of age at the early stage the disease



Primary Outcome Measures :
  1. Number of successfully identified participants [ Time Frame: one year ]
    The successful outcome will be measured as 15 successful identifications of patients with Parkinson's disease (PD) out of 20 subjects of 10 PD patients and 10 healthy controls



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   25 Years to 82 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

PD patients will be selected from the primary care clinic in Claxton - Hepburn Medical Center, Ogdensburg NY. The healthy participants will be selected from the population of St. Lawrence County, NY.

Selection of PD patients: PD confirmed, but with mild symptoms Selection of healthy controls: match in age/gender/education level/profession/etc. if possible.

Criteria

Inclusion Criteria:

  • Early PD (diagnosed within 6 months)
  • Older than 18 years old

Exclusion Criteria:

  • Less than 18 years old
  • Not taking anti depressants

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02168504


Locations
Layout table for location information
United States, New York
Norconnect Inc.
Ogdensburg, New York, United States, 13669
Sponsors and Collaborators
Norconnect Inc
Michael J. Fox Foundation for Parkinson's Research
Investigators
Layout table for investigator information
Principal Investigator: Michael Linderman, M. Sc. Eng Norconnect Inc
Additional Information:
Layout table for additonal information
Responsible Party: Norconnect Inc
ClinicalTrials.gov Identifier: NCT02168504    
Other Study ID Numbers: ESBPD_170614
100/2310 ( Other Identifier: Michael J. Fox Foundation )
First Posted: June 20, 2014    Key Record Dates
Last Update Posted: October 8, 2015
Last Verified: October 2015
Additional relevant MeSH terms:
Layout table for MeSH terms
Parkinson Disease
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases